RxDoctor Payments Data
★ My doctorsLook up a doctor →

Matthew Burrus, MD

Orthopaedic Surgery · Austin, TXNPI 1538458526

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 95.9% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2024 at $41,088 and has fallen 81.1% since, to $7,759 in 2025. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$116,896in general payments, 2019–2025

Across 351 payments — averaging $333.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$112K
  • Medinc Of Texas$3K
  • Core Surgical Group$548
  • Stryker$337
  • Pacira Therapeutics, Inc.$323
  • Smith+Nephew$226
  • plus $594 from 15 others
$20,852in research payments, 2019–2025

Across 15 payments — averaging $1390.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$17K
  • Arthrex$4K

What the payments were for

  • Consulting fees$56,52748%
  • Speaking & faculty fees$35,92931%
  • Travel & lodging$16,26514%
  • Food & beverage$6,0885%
  • Education$2,0872%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex263$112,078
Medinc Of Texas7$2,790
Core Surgical Group5$548
Stryker6$337
Pacira Therapeutics, Inc.34$323
Smith+Nephew3$226
Ferring Pharmaceuticals Inc.9$146
Johnson & Johnson3$74
Misonix Inc1$54
Abbott3$50
Linvatec Corporation1$39
Orthofix Medical, Inc.5$37
Radius Health, Inc.2$36
FX Shoulder Solutions, Inc1$30
Acera Surgical, Inc.1$30
Vericel Corporation1$24
Si-bone, Inc.1$23
Fidia Pharma USA Inc.2$14
Arthrosurface Incorporated1$14
Amgen1$12
Bioventus LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$116,896 in reported general payments places this provider in the 90th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$136,568
Medicare patients
245
Services billed
9,583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam200$463
Oxycodone Hcl51$407
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$265
Methylprednisolone27$160
Tramadol Hcl20$90

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →